Rizza et al., 2021 - Google Patents
IL-6 levels influence 3-month all-cause mortality in frail hospitalized older patientsRizza et al., 2021
View HTML- Document ID
- 3336136733646817804
- Author
- Rizza S
- Morabito P
- De Meo L
- Farcomeni A
- Testorio G
- Cardellini M
- Ballanti M
- Davato F
- Pecchioli C
- Di Cola G
- Mavilio M
- Federici M
- Publication year
- Publication venue
- Aging and disease
External Links
Snippet
The multidimensional prognostic index (MPI) is a sensitive and specific prognosis estimation tool that accurately predicts all-cause mortality in frail older patients. It has been validated to assess the risk of 1-month to 2-year mortality in frail older patients during hospitalization and …
- 108090001005 Interleukin-6 0 title description 24
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chaulin | Cardiac troponins: contemporary biological data and new methods of determination | |
| Yaffe et al. | Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study | |
| Tavil et al. | Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients | |
| Huang et al. | The relationship between mean telomere length and blood pressure: results from the National Health and Nutrition Examination Surveys | |
| Tang et al. | Performance of high-sensitivity cardiac troponin assays to reflect comorbidity burden and improve mortality risk stratification in older adults with diabetes | |
| Lisiak et al. | Frailty and quality of life in elderly patients with acute coronary syndrome | |
| Heikkilä et al. | Associations of coeliac disease with coronary heart disease and cerebrovascular disease: A systematic review and meta-analysis | |
| She et al. | Serum uric acid to creatinine ratio and risk of metabolic syndrome in patients with overweight/obesity | |
| Vernekar et al. | Comparison of mean platelet volume in type 2 diabetics on insulin therapy and on oral hypoglycaemic agents | |
| Martin et al. | Predicting ICU readmission among surgical ICU patients: Development and validation of a clinical nomogram | |
| Schutte et al. | Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression | |
| Rizza et al. | IL-6 levels influence 3-month all-cause mortality in frail hospitalized older patients | |
| Song et al. | Diagnosing metabolic syndrome in type 2 diabetes: does it matter? | |
| Gu et al. | The association between red blood cell distribution width and the severity of diabetic chronic kidney disease | |
| Vaucher et al. | Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms | |
| Kavsak et al. | Identifying very-low-risk patients for future myocardial infarction or death | |
| Wang et al. | High level of serum uric acid induced monocyte inflammation is related to coronary calcium deposition in the middle-aged and elder population of China: a five-year prospective cohort study | |
| Cayuela et al. | Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost? | |
| Mumma et al. | Diagnostic reclassification by a high-sensitivity cardiac troponin assay | |
| He et al. | Sex-specific differences in the effect of lymphocyte-to-C-reactive protein ratio on subclinical myocardial injury in the general population free from cardiovascular disease | |
| Huang et al. | U-shaped association of uric acid to HDL cholesterol ratio (UHR) with ALL-cause and cardiovascular mortality in diabetic patients: NHANES 1999–2018 | |
| Cui et al. | Association between Age and the 28-Day all-cause Mortality in Tuberculosis complicated by Sepsis in ICU patients: a retrospective cohort study | |
| Yang et al. | The impact of nutritional and inflammatory status on mortality in stroke patients: Results from NHANES 2005-2018 | |
| Kavsak et al. | High-sensitivity cardiac troponin I vs a clinical chemistry score for predicting all-cause mortality in an emergency department population | |
| Di Chiara et al. | Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities |